University of Colorado Dept. of Anschutz Cancer (3) — Aurora, Colorado

University of Colorado Dept. of Anschutz Cancer (3) is a clinical research site located in Aurora, Colorado, United States 80045.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Colorado Dept. of Anschutz Cancer (3) has participated in 2 clinical trials.

Therapeutic areas: Anaplastic Lymphoma Kinase (ALK), Non-small Cell Lung Cancer, Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Colorado Dept. of Anschutz Cancer (3)?

University of Colorado Dept. of Anschutz Cancer (3) has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Colorado Dept. of Anschutz Cancer (3) conducted?

University of Colorado Dept. of Anschutz Cancer (3) has 2 clinical trials on record. Their work covers Anaplastic Lymphoma Kinase (ALK), Non-small Cell Lung Cancer, Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3.

Is University of Colorado Dept. of Anschutz Cancer (3) accredited by Crixeo Health?

University of Colorado Dept. of Anschutz Cancer (3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Colorado Dept. of Anschutz Cancer (3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.